COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
NASDAQ:COLL • US19459J1043
45.17 USD
+0.32 (+0.71%)
At close: Feb 24, 2026
45.17 USD
0 (0%)
After Hours: 2/24/2026, 8:18:21 PM
Taking everything into account, COLL scores 6 out of 10 in our fundamental rating. COLL was compared to 192 industry peers in the Pharmaceuticals industry. COLL has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on COLL. With these ratings, COLL could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
- COLL had positive earnings in the past year.
- In the past year COLL had a positive cash flow from operations.
- Of the past 5 years COLL 4 years were profitable.
- Each year in the past 5 years COLL had a positive operating cash flow.
1.2 Ratios
- COLL has a better Return On Assets (3.64%) than 84.38% of its industry peers.
- The Return On Equity of COLL (21.27%) is better than 91.15% of its industry peers.
- COLL has a Return On Invested Capital of 9.10%. This is amongst the best in the industry. COLL outperforms 88.54% of its industry peers.
- COLL had an Average Return On Invested Capital over the past 3 years of 11.08%. This is in line with the industry average of 12.96%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.64% | ||
| ROE | 21.27% | ||
| ROIC | 9.1% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
- COLL has a Profit Margin of 7.72%. This is amongst the best in the industry. COLL outperforms 82.81% of its industry peers.
- COLL's Profit Margin has declined in the last couple of years.
- COLL's Operating Margin of 20.74% is amongst the best of the industry. COLL outperforms 88.54% of its industry peers.
- COLL's Operating Margin has improved in the last couple of years.
- With a decent Gross Margin value of 57.22%, COLL is doing good in the industry, outperforming 69.27% of the companies in the same industry.
- In the last couple of years the Gross Margin of COLL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.74% | ||
| PM (TTM) | 7.72% | ||
| GM | 57.22% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
- COLL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- COLL has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for COLL has been reduced compared to 5 years ago.
- The debt/assets ratio for COLL has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.45, we must say that COLL is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of 1.45, COLL perfoms like the industry average, outperforming 58.85% of the companies in the same industry.
- COLL has a debt to FCF ratio of 2.79. This is a good value and a sign of high solvency as COLL would need 2.79 years to pay back of all of its debts.
- The Debt to FCF ratio of COLL (2.79) is better than 92.19% of its industry peers.
- COLL has a Debt/Equity ratio of 2.71. This is a high value indicating a heavy dependency on external financing.
- COLL's Debt to Equity ratio of 2.71 is on the low side compared to the rest of the industry. COLL is outperformed by 80.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 2.79 | ||
| Altman-Z | 1.45 |
ROIC/WACC1
WACC9.14%
2.3 Liquidity
- COLL has a Current Ratio of 1.36. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of COLL (1.36) is worse than 73.96% of its industry peers.
- COLL has a Quick Ratio of 1.27. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
- COLL's Quick ratio of 1.27 is on the low side compared to the rest of the industry. COLL is outperformed by 68.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 30.73% over the past year.
- Measured over the past years, COLL shows a very strong growth in Earnings Per Share. The EPS has been growing by 154.78% on average per year.
- The Revenue has grown by 26.34% in the past year. This is a very strong growth!
- The Revenue has been growing by 16.31% on average over the past years. This is quite good.
EPS 1Y (TTM)30.73%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%39.75%
Revenue 1Y (TTM)26.34%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%31.42%
3.2 Future
- COLL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.05% yearly.
- Based on estimates for the next years, COLL will show a small growth in Revenue. The Revenue will grow by 4.61% on average per year.
EPS Next Y18.1%
EPS Next 2Y12.08%
EPS Next 3Y-0.6%
EPS Next 5Y0.05%
Revenue Next Year24.13%
Revenue Next 2Y13.42%
Revenue Next 3Y4.47%
Revenue Next 5Y4.61%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- COLL is valuated cheaply with a Price/Earnings ratio of 6.28.
- Compared to the rest of the industry, the Price/Earnings ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 95.83% of the companies listed in the same industry.
- COLL is valuated cheaply when we compare the Price/Earnings ratio to 26.98, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 5.57 indicates a rather cheap valuation of COLL.
- Based on the Price/Forward Earnings ratio, COLL is valued cheaper than 94.79% of the companies in the same industry.
- COLL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.28 | ||
| Fwd PE | 5.57 |
4.2 Price Multiples
- COLL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. COLL is cheaper than 97.40% of the companies in the same industry.
- COLL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. COLL is cheaper than 96.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.94 | ||
| EV/EBITDA | 4.71 |
4.3 Compensation for Growth
- COLL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- COLL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y12.08%
EPS Next 3Y-0.6%
5. Dividend
5.1 Amount
- COLL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
45.17
+0.32 (+0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-26 2026-02-26/amc
Inst Owners120.33%
Inst Owner Change0.37%
Ins Owners1.42%
Ins Owner Change2.01%
Market Cap1.43B
Revenue(TTM)757.07M
Net Income(TTM)58.44M
Analysts81.67
Price Target54.23 (20.06%)
Short Float %15.42%
Short Ratio10.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.9%
Min EPS beat(2)1.88%
Max EPS beat(2)7.92%
EPS beat(4)4
Avg EPS beat(4)6.15%
Min EPS beat(4)1.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)12.99%
EPS beat(12)9
Avg EPS beat(12)-15.06%
EPS beat(16)10
Avg EPS beat(16)-21.97%
Revenue beat(2)2
Avg Revenue beat(2)5.22%
Min Revenue beat(2)1.9%
Max Revenue beat(2)8.53%
Revenue beat(4)3
Avg Revenue beat(4)2.75%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)8.53%
Revenue beat(8)4
Avg Revenue beat(8)0.8%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)8
Avg Revenue beat(16)-3.75%
PT rev (1m)0%
PT rev (3m)19.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.38%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.28 | ||
| Fwd PE | 5.57 | ||
| P/S | 1.89 | ||
| P/FCF | 4.94 | ||
| P/OCF | 4.91 | ||
| P/B | 5.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.71 |
EPS(TTM)7.19
EY15.92%
EPS(NY)8.1
Fwd EY17.94%
FCF(TTM)9.15
FCFY20.26%
OCF(TTM)9.2
OCFY20.38%
SpS23.95
BVpS8.69
TBVpS-18.86
PEG (NY)0.35
PEG (5Y)N/A
Graham Number37.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.64% | ||
| ROE | 21.27% | ||
| ROCE | 13.6% | ||
| ROIC | 9.1% | ||
| ROICexc | 12.09% | ||
| ROICexgc | N/A | ||
| OM | 20.74% | ||
| PM (TTM) | 7.72% | ||
| GM | 57.22% | ||
| FCFM | 38.21% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score7
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 2.79 | ||
| Debt/EBITDA | 1.94 | ||
| Cap/Depr | 0.72% | ||
| Cap/Sales | 0.21% | ||
| Interest Coverage | 2.17 | ||
| Cash Conversion | 75.92% | ||
| Profit Quality | 495.01% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 1.45 |
F-Score7
WACC9.14%
ROIC/WACC1
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.73%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%39.75%
EPS Next Y18.1%
EPS Next 2Y12.08%
EPS Next 3Y-0.6%
EPS Next 5Y0.05%
Revenue 1Y (TTM)26.34%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%31.42%
Revenue Next Year24.13%
Revenue Next 2Y13.42%
Revenue Next 3Y4.47%
Revenue Next 5Y4.61%
EBIT growth 1Y-18.86%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year157.27%
EBIT Next 3Y28.14%
EBIT Next 5Y19.55%
FCF growth 1Y8.55%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y8.67%
OCF growth 3Y25.54%
OCF growth 5Y49.12%
COLLEGIUM PHARMACEUTICAL INC / COLL FAQ
What is the ChartMill fundamental rating of COLLEGIUM PHARMACEUTICAL INC (COLL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to COLL.
What is the valuation status for COLL stock?
ChartMill assigns a valuation rating of 9 / 10 to COLLEGIUM PHARMACEUTICAL INC (COLL). This can be considered as Undervalued.
What is the profitability of COLL stock?
COLLEGIUM PHARMACEUTICAL INC (COLL) has a profitability rating of 8 / 10.
Can you provide the financial health for COLL stock?
The financial health rating of COLLEGIUM PHARMACEUTICAL INC (COLL) is 5 / 10.